Sareum Share News (SAR)

Sareum Information

Buy SAR Shares
Add SAR to Watchlist
Add SAR to Alert

Share Price Information for Sareum (SAR)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 47.00

Bid: 46.00

Ask: 48.00

Change: 1.70 (3.91%)

Spread: 2.00 (4.348%)

Open: 43.50

High: 47.50

Low: 45.00

Prev. Close: 43.50

Last checked at -

IN BRIEF: Sareum Holdings draws down on equity prepayment facility

Thu, 23rd Nov 2023 14:28

Sareum Holdings PLC - Cambridge, England-based pharmaceutical company, focused on developing kinase inhibitors to treat autoimmune diseases and cancer - Says that it has drawn down on the GBP300,000 second deposit in respect of a previously announced equity prepayment facility.

In accordance with the terms of the facility, Sareum will issue 227,892 four year warrants over ordinary shares of 1.25p, each exercisable at a price of 82.93p to RiverFort Global Opportunities PLC.

Current stock price: 63.50 pence, up 1.6%

12-month change: down 23%

By Holly Beveridge, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

More News

12 May 2015 09:37

Sareum Holdings Up As CEO Gets Ready To Present At Partnering Conference

7 May 2015 11:28

LONDON MIDDAY BRIEFING: Morrison Sales Continue To Decline

7 May 2015 10:26

WINNERS & LOSERS: Morrisons Sales Decline Sinks Shares

7 May 2015 09:19

Sareum Says Equity Swap Deal With YA Global Master Ends Early (ALLISS)

25 Feb 2015 11:32

Sareum Cautiously Optimistic As It Posts Widened First Half Loss

20 Jan 2015 08:11

Sareum Gets Further US Patent Protection For Kinase Inhibitors

10 Nov 2014 08:55

Sareum Granted European Patent For Kinase Inhibitor Compounds

14 Oct 2014 08:56

Sareum Holdings Sees Widened Loss As It Focuses On Commercialisation

1 Oct 2014 11:54

Sareum reports progress with psoriasis drug development programme

Drug development firm Sareum and its partner SRI International have reported progress with its drug development programme for the autoimmune disease psoriasis. Psoriasis can occur when the production of cytokines is not properly regulated and immune cells are consequently overly activated. The cyct

1 Oct 2014 08:06

Sareum Sees "Promising Step" In Potential Psoriasis Drug

22 Sep 2014 08:16

Sareum Granted EU Patent For CHKI Cancer Programme Invention

2 Jul 2014 07:49

Sareum Holdings Granted Japanese Patent For Kinase Inhibitors

13 Jun 2014 07:32

Sareum Holdings Raises New Money From YA Global Master

LONDON (Alliance News) - Sareum Holdings PLC Friday said it has raised GBP550,000 through a new placing and equity swap with YA Global Master SPV Ltd, money it will use for working capital and to fund its main research programmes. The specialist cancer drug company said YA Global Master ha

26 Feb 2014 15:19

UK MIDDAY BRIEFING: ITV Punished For Not Paying Out More

LONDON (Alliance News) - ITV reported higher profits and revenues for 2013 and gave a bullish outlook for 2014, but has seen its shares punished Wednesday after it failed to increase its special dividend. The television company raised its total dividend for 2013 to 3.5 pence, from 2.6 pence

26 Feb 2014 12:24

UK WINNERS & LOSERS: Contrarian Price Moves For ITV And Weir Shares

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Wednesday.

-------

FTSE 100 - WINNERS

Weir Group, up 6.5%. Despite reporting a fall in profit and revenue fo

Latest Share Chat

Sareum Share News (SAR)

Share Price Information for Sareum (SAR)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Sareum Holdings draws down on equity prepayment facility

Login to your account

Quickpicks are a member only feature

Login to your account